ELIZABETH HILL to Treatment Outcome
This is a "connection" page, showing publications ELIZABETH HILL has written about Treatment Outcome.
Connection Strength
0.022
-
Remission and Progression-Free Survival in Patients With Newly Diagnosed Multiple Myeloma Treated With Carfilzomib, Lenalidomide, and Dexamethasone: Five-Year Follow-up of a Phase 2 Clinical Trial. JAMA Oncol. 2018 12 01; 4(12):1781-1783.
Score: 0.013
-
Management of pediatric craniocervical arterial dissections. Childs Nerv Syst. 2015 Jan; 31(1):101-7.
Score: 0.010